Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

42

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

Tags:

Previous Article

Defining microglial-synapse interactions

Clinical sequelae of gut microbiome development and disruption in hospitalized p...

Related Posts

Reversible reduction in brain myelin content upon marathon running

Reversible reduction in brain myelin content upon marat...

63

Multi-omics architecture of childhood obesity and metabolic dysfunction uncovers biological pathways and prenatal determinants

Multi-omics architecture of childhood obesity and metab...

46

Varroa destructor: A Complex Parasite, Crippling Honey Bees Worldwide

Varroa destructor: A Complex Parasite, Crippling Honey ...

32